Fulvestrant does not stimulate endometrial growth in postmenopausal breast cancer patients

被引：0
|
作者：
Morales, L. [1 ]
Neven, P. [1 ]
Timmerman, D. [1 ]
Wildiers, H. [1 ]
Konstantinovic, M. L. [1 ]
Tan, P. N. [1 ]
Christiaens, M-R [1 ]
Paridaens, R. [1 ]
机构：
[1] Univ Hosp KU Leuven, Fac Med, Louvain, Belgium
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S116 / S116
页数：1
相关论文
共 50 条
  • [1] Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients
    Poggio, Francesca
    Lambertini, Matteo
    Blondeaux, Eva
    Vaglica, Marina
    Levaggi, Alessia
    Pronzato, Paolo
    Del Mastro, Lucia
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (09) : 1153 - 1161
  • [2] Fulvestrant in postmenopausal women with advanced breast cancer
    Bross, PF
    Baird, A
    Chen, G
    Jee, JM
    Lostritto, RT
    Morse, DE
    Rosario, LA
    Williams, GM
    Yang, PL
    Rahman, A
    Williams, G
    Pazdur, R
    CLINICAL CANCER RESEARCH, 2003, 9 (12) : 4309 - 4317
  • [3] Role of fulvestrant in the management of postmenopausal breast cancer
    Krell, Jonathan
    Januszewski, Adam
    Yan, Kelvin
    Palmieri, Carlo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (11) : 1641 - 1652
  • [4] Prospective assessment of the endometrium in postmenopausal breast cancer patients treated with fulvestrant
    Leilani Morales
    Patrick Neven
    Dirk Timmerman
    Hans Wildiers
    Maja L. Konstantinovic
    Marie-Rose Christiaens
    Peter N. Tan
    Robert Paridaens
    Breast Cancer Research and Treatment, 2009, 117
  • [5] Prospective assessment of the endometrium in postmenopausal breast cancer patients treated with fulvestrant
    Morales, Leilani
    Neven, Patrick
    Timmerman, Dirk
    Wildiers, Hans
    Konstantinovic, Maja L.
    Christiaens, Marie-Rose
    Tan, Peter N.
    Paridaens, Robert
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (01) : 77 - 81
  • [6] Bone turnover markers in postmenopausal breast cancer patients treated with fulvestrant
    Robertson, J. F. R.
    Agrawal, A.
    Hannon, R. A.
    Cheung, K. L.
    Eastell, R.
    BREAST, 2007, 16 : S53 - S53
  • [7] The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer
    Rupert Bartsch
    Brigitte Mlineritsch
    Michael Gnant
    Thomas Niernberger
    Ursula Pluschnig
    Richard Greil
    Catharina Wenzel
    Paul Sevelda
    Josef Thaler
    Margaretha Rudas
    Michael Pober
    Christoph C. Zielinski
    Guenther G. Steger
    Breast Cancer Research and Treatment, 2009, 115 : 373 - 380
  • [8] The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer
    Bartsch, Rupert
    Mlineritsch, Brigitte
    Gnant, Michael
    Niernberger, Thomas
    Pluschnig, Ursula
    Greil, Richard
    Wenzel, Catharina
    Sevelda, Paul
    Thaler, Josef
    Rudas, Margaretha
    Pober, Michael
    Zielinski, Christoph C.
    Steger, Guenther G.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 115 (02) : 373 - 380
  • [9] Fulvestrant in the treatment of postmenopausal women with advanced breast cancer
    Gradishar, W
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (03) : 445 - 453
  • [10] Bone turnover markers in postmenopausal breast cancer patients treated with fulvestrant.
    Agrawal, A.
    Hannon, R. A.
    Cheung, K. L.
    Eastell, R.
    Robertson, J. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 47S - 47S
12345